Compare Generiks Inc Sample Contracts

Compare Generiks Inc – AMENDMENT AGREEMENT (June 28th, 1999)

AMENDMENT AGREEMENT THIRD AMENDMENT AGREEMENT, dated as of January 4, 1999 by and between PDK Labs Inc., a New York corporation, with offices at 145 Ricefield Lane, Hauppauge, NY 11788 ("PDK") and Compare Generiks, Inc., a Delaware corporation, with offices at 300 Oser Avenue, Hauppauge, NY 11788 ("CGI"). WHEREAS, PDK and CGI have heretofore entered into an Exclusive Supply and Licensing Agreement, dated as of March 24, 1997, which has been amended pursuant to the Amendment Agreements dated as of April 1, 1998 and November 1, 1998 (the "Agreement"); WHEREAS, Section 6.1(c) of the Agreement requires CGI to pay to PDK a license fee of $500,000 ("License Fee") for each Agreement Year (as defined in the Agreement) in consideration of the License (as defined in the Agreement) granted by PDK to CGI which License Fee is payable in cash or common stock of CGI WHEREAS, the parties desire to grant CGI the additional optio

Compare Generiks Inc – GUARANTY (June 28th, 1999)

GUARANTY WHEREAS, European American Bank and the parties identified. as "Banks" therein (the "Banks") have entered into a Credit Agreement (the "Credit Agreement", dated August 20, 1997, with PDK Labs Inc. and Futurebiotics, Inc. (the "Debtor); and WHEREAS, under the terms of the Credit Agreement, the Banks have agreed to extend credit to the Debtors, which indebtedness is evidenced by certain promissory notes of the Debtors (the "Notes"), to be dated on and after August 13, 1998, in the aggregate principal amount of $18,500,000; WHEREAS, the undersigned (the "Guarantor") has derived or will derive direct benefit from the extension of credit to the Debtors; and WHEREAS, the Banks will not extend such credit unless, among other conditions, the undersigned Guarantor shall have executed and delivered this Guaranty, NOW, THEREFORE, in consideration of the Banks extending such credit to the

Compare Generiks Inc – AMENDMENT AGREEMENT (June 29th, 1998)

AMENDMENT AGREEMENT AMENDMENT AGREEMENT, dated as of April 1, 1998 by and between PDK Labs Inc., a New York corporation, with offices at 145 Ricefield Lane, Hauppauge, NY 11788 ("PDK") and Compare Generiks, Inc., a Delaware corporation, with offices at 300 Oser Avenue, Hauppauge, NY 11788 ("CGI"). WHEREAS, PDK and CGI have heretofore entered into an Exclusive Supply and Licensing Agreement, dated as of March 24, 1997 (the "Agreement"); WHEREAS, Section 2(d) of the Agreement requires CGI to pay invoices within sixty (60) days of the date of shipment of the related Products (as defined in the Agreement); WHEREAS, the Agreement contains a provision permitting PDK to suspend its obligations to perform under the Agreement in the event of an Event of Force Majeure (as defined in the Agreement); WHEREAS, the Agreement contains a provision (the "Payment Provision") providing for the payment by CGI to PDK of a

Compare Generiks Inc – EXCLUSIVE SUPPLY AGREEMENT (June 30th, 1997)

Exhibit 10.11 EXCLUSIVE SUPPLY AGREEMENT This Exclusive Supply Agreement (the "Agreement") is made and entered into as of the 31st day of May, 1996 by and between Superior Supplements, Inc., a Delaware corporation ("SSI"), and Compare Generiks, Inc., a Delaware corporation ("CGI"). W I T N E S S E T H: WHEREAS, SSI is engaged in the business of manufacturing and distributing certain vitamins in bulk tablet form; and WHEREAS, SSI owns and operates a factory for the manufacture of vitamins in bulk tablet form; and WHEREAS, CGI is engaged in the business of marketing and distributing vitamin products. NOW, THEREFORE, the parties for good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, agree as follows: 1. Exclusive Purchase and Sale of Products.

Compare Generiks Inc – EXCLUSIVE SUPPLY AND LICENSING AGREEMENT (June 30th, 1997)

EXCLUSIVE SUPPLY AND LICENSING AGREEMENT This Supply and Licensing Agreement (the "Agreement") is made and entered into as of the 24th day of March, 1997 by and between PDK Labs Inc., a New York corporation ("PDK"), and Compare Generiks, Inc., a Delaware corporation ("CGI"). W I T N E S S E T H: WHEREAS, PDK is engaged in the business of manufacturing, marketing and distributing vitamins, herbs and non-prescription pharmaceutical products; and WHEREAS, PDK owns and operates a factory for the manufacture of vitamins and non-prescription pharmaceutical products; and WHEREAS, CGI is engaged in the business of marketing and distributing dietary supplements and over-the-counter non-prescription pharmaceutical products; and WHEREAS, PDK and CGI desire that PDK sell to CGI and CGI wishes to purchase from PDK, certain products manufactured by PDK in its "Max Brand" and "HeadsUp" product ran

Compare Generiks Inc – MARKETING AGREEMENT (June 30th, 1997)

MARKETING AGREEMENT This Marketing Agreement (the "Agreement") is made and entered into as of the 5th day of May, 1997 by and between Compare Generiks, Inc., a Delaware corporation ("CGI") and Body Dynamics, Inc., an Indiana corporation ("BDI"). W I T N E S S E T H: WHEREAS, CGI is engaged in the business of marketing and distributing dietary supplements and over-the-counter non-prescription pharmaceutical products; and WHEREAS, BDI is engaged in the business of marketing vitamin, herbs and non-prescription pharmaceutical products; and WHEREAS, CGI and BDI wish to enter into an agreement whereby BDI markets certain products distributed by CGI in the "Max Brand" and "HeadsUp" product ranges; and WHEREAS, BDI acknowledges that CGI may incur substantial expenses and may expend significant resources in order to acquire additional equipment, incur obligations and employ additi

Compare Generiks Inc – AMENDMENT AGREEMENT (June 30th, 1997)

Exhibit 10.12 AMENDMENT AGREEMENT AMENDMENT AGREEMENT, dated as of December 13, 1996 by and between PDK Labs Inc., a New York corporation, with offices at 145 Ricefield Lane, Hauppauge, NY 11788 ("PDK") and, Compare Generiks, Inc., (formerly Lesser Paul, Inc.) a Delaware corporation, with offices at 300 Oser Avenue, Hauppauge, NY 11788 ("CGI"). WHEREAS, PDK and CGI have heretofore entered into an Agreement (the "Agreement"), dated as of October 31, 1995. WHEREAS, the Agreement contains a provision providing for the payment by CGI to PDK of an amount equal to PDK's Material Cost (as defined in the Agreement) plus one hundred percent (100%) for the Pills (as defined in the Agreement) supplied pursuant thereto, which provision the parties hereto desire to amend to provide for the payment by CGI to PDK of an amount equal to PDK's Material Cost plus $.05 per bot